Y-90 SIRT for Unresectable HCC Larger Than 7cm

Clinical trial NCT06707233 · RECRUITING

Trial details

NCT number: NCT06707233
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-Resectable

Start date: 2024-12-01
Primary completion: 2026-11-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.